Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on
Credit: Reuters
Sept 21 (Reuters) - Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of biotech listings in the fall window.